Summary: The FDA has approved Zepbound (tirzepatide) as the first prescription medication for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. Clinical trial results from the SURMOUNT-OSA phase 3 studies showed that Zepbound significantly reduced breathing interruptions during sleep and promoted substantial weight loss when combined with a reduced-calorie diet and physical activity. Nearly…
By Sree Roy When the WatchPAT home sleep test (HST) entered the US market, the idea that a home-based device could supply a reliable apnea-hypopnea index (AHI)—without a sensor in the nose, at that—was inconceivable. During a time when sleep testing was almost exclusively done in the lab and always involved direct airflow sensing, “Itamar,…
December 20, 2024 • Research Highlight Despite decades of research and the availability of antiretroviral medications, HIV continues to pose a significant health challenge. While these medications can be used to eliminate the symptoms of HIV and prevent its spread to others, a cure has yet to be found.One major challenge is that HIV can…
Charles Spurgeon spoke of depression as the soul relentlessly bleeding out — like one who dies again and again, hour upon hour. The mind can descend far lower than the body, for in it there are bottomless pits. The flesh can bear only a certain number of wounds and no more, but the soul can…